Damian Garde

Damian Garde, a reporter at large for STAT and former co-host, joins to dive into the excitement surrounding the J.P. Morgan Healthcare Conference. He reveals why pharma CEOs are optimistic about upcoming deals and discusses the recent FDA approval of Novo Nordisk's Wegovy pill. The conversation also touches on changes to pediatric immunizations and the landscape of biotech mergers and acquisitions, including the buzz around Revolution Medicines. Garde highlights the evolving pharma sentiments and the impact of White House agreements on pricing and tariffs.